Intel shares slip on reports Nvidia halted 18A chip test

Shares of Intel fell after a Reuters report citing unnamed sources said Nvidia halted evaluation of Intel’s advanced 18A chipmaking process, with Intel stock down 3.1% to $35 while Nvidia slipped 0.3% to $188. The report — which Intel disputed by saying its 18A technologies are progressing well and to which Nvidia declined comment — raises concerns about demand traction for Intel’s leading-edge process and adds pressure amid intense competition in semiconductor manufacturing for AI chips. For portfolio managers, the development is a near-term negative signal on Intel’s competitiveness in advanced nodes and may warrant reassessment of exposure to wafer-fabrication execution risk in the semiconductor sector.

Analysis

Market structure: Immediate winners are TSMC (TSM) and semiconductor-equipment makers (ASML, LRCX) as hyperscalers and AI chip designers prefer proven advanced-node capacity; losers are INTC (down 3.1% to $35) and its foundry-supply chain who face delayed revenue recognition and weaker pricing leverage. Competitive dynamics shift incremental pricing power to TSMC/Samsung for 3–18 months of AI wafer demand, likely sustaining spot premiums at the advanced-node layer (roughly +5–15% vs pre-shock levels) until new capacity is confirmed.

Risk assessment: Tail risks include a technical failure at Intel 18A forcing a $5–10bn capex write-down or customer defections that materially compress INTC margins, and regulatory scrutiny if major customers coordinate supply shifts (6–18 months). Near-term (days-weeks) expect headline-driven volatility; short-term (3–6 months) will be driven by customer test announcements; long-term (12–36 months) depends on node economics, yield curves and capex cadence.

Trade implications: Tactical plays favor modest INTC downside protection and reallocation into TSM/ASML; expect elevated INTC implied volatility — use defined-risk option structures. Rotate 1–3% overweight into semicap equipment and foundries over 6–12 months, trimming on negative order-book revisions or if INTC posts credible 18A yield milestones.

Contrarian angles: The market may be overreacting to an unconfirmed test halt — a single vendor decision is not proof of node failure and could reverse on a positive Intel update within 60–90 days, producing a >20% upside squeeze. Historical parallel: early AMD/TSMC dependency was initially punished then rewarded after execution; prioritize milestone-driven entries rather than headline chasing.

Key Decisions for Investors

• Establish a tactical bearish, defined-risk position on INTC: buy a Mar-2026 32/28 put vertical (debit) sized to risk 0.5–1.0% of portfolio; target 2.5x payout if INTC < $28 by Mar-2026; cut position if INTC > $38 or implied vol falls >35% from entry.
• Implement a relative-value pair: go long TSM (TSM) 2–3% net exposure financed by a 2% notional short in INTC (equal-dollar); objective is TSM outperformance of 15–25% over 6–12 months; trim long TSM if TSM’s capacity guidance is cut or underperforms NVDA by >12% over a rolling 60 days.
• Rotate into semiconductor-equipment names: increase ASML (ASML) exposure by 1.5% and LRCX by 1.0% (or buy a 9–12 month ASML 20/30 call spread for leveraged exposure); target +20–30% over 12 months driven by tool backlog; exit if combined equipment order-book growth falls quarter-over-quarter.
• Maintain event-based rules: monitor three concrete triggers — (1) Intel 18A yield/milestone disclosure (target >50% usable die) within 90 days, (2) Nvidia or other major fab customer committing to TSM/Samsung capacity in next 60–120 days, (3) ASML shipments/ship dates. If trigger (1) is met, reduce INTC bearish positions by 50% within 5 trading days; if triggers (2) or (3) confirm supply reallocation, add to TSM/ASML positions up to +1% each.